openPR Logo

Press Releases from Cardiovascular Disease (8 total)

Deep Research: Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class …

Researchmoz added Most up-to-date research on "Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" to its huge collection of research reports. An insight on the important factors and trends influencing the market. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD

Clinical Trials On Cardiovascular Disease: Frontier Pharma

Researchmoz added Most up-to-date research on "Clinical Trials On Cardiovascular Disease: Frontier Pharma" to its huge collection of research reports. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque building up within blood vessels. As atheroma develops it causes the affected blood

Market Overview of Cardiovascular Disease Industry 2018

Albany, NY, 3rd January : Recent research and the current scenario as well as future market potential of "Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" globally. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1313843 The most crucial risk

Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unme …

Researchmoz added Most up-to-date research on "Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" to its huge collection of research reports. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque building up

Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targe …

ResearchMoz added Latest Research Report titled " Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis " to it's Large Report database. Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis Summary The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood

Treatments Of Cardiovascular Disease - Diverse First-in-Class Molecular Targets …

Researchmoz added Most up-to-date research on "Treatments Of Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" to its huge collection of research reports. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque

Global Cardiovascular Disease In-Depth Industrial and Market studies to 2022 - S …

Albany, New York, Feb 22, 2017 Description- Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia of which accelerate the development of atherosclerotic plaques building up within blood vessels. As atheroma develops its causes stenosis of the blood vessels which can restrict blood flow to the body, brain or heart depending on its

Therapeutics Global Market For Cardiovascular Disease 2022 - Sanofi And Novartis …

ResearchMoz presents this most up-to-date research on "Therapeutics Global Market For Cardiovascular Disease 2022 - Sanofi And Novartis To Become Market Leaders As Praluent & Entresto Drive Revenue Growth". Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia of which accelerate the development of atherosclerotic plaques building up within blood vessels. As